{"version":"1.0","type":"link","title":"Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE.","author_name":"Potthoff K 외","author_url":"https://prs-insight.online/author/Potthoff%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/107232","thumbnail_width":1200,"thumbnail_height":630}